299 related articles for article (PubMed ID: 2551456)
1. The effect of the excitatory amino acid receptor antagonist dizocilipine maleate (MK-801) on hemispheric cerebral blood flow and metabolism in dogs: modification by prior complete cerebral ischemia.
Perkins WJ; Lanier WL; Karlsson BR; Milde JH; Michenfelder JD
Brain Res; 1989 Sep; 498(1):34-44. PubMed ID: 2551456
[TBL] [Abstract][Full Text] [Related]
2. The effects of dizocilpine maleate (MK-801), an antagonist of the N-methyl-D-aspartate receptor, on neurologic recovery and histopathology following complete cerebral ischemia in primates.
Lanier WL; Perkins WJ; Karlsson BR; Milde JH; Scheithauer BW; Shearman GT; Michenfelder JD
J Cereb Blood Flow Metab; 1990 Mar; 10(2):252-61. PubMed ID: 2154509
[TBL] [Abstract][Full Text] [Related]
3. The effects of N-methyl-D-aspartate receptor blockade with MK-801 upon the relationship between cerebral blood flow and glucose utilisation.
Nehls DG; Park CK; MacCormack AG; McCulloch J
Brain Res; 1990 Mar; 511(2):271-9. PubMed ID: 2159360
[TBL] [Abstract][Full Text] [Related]
4. Systematic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEG, and blood-brain barrier following complete reversible cerebral ischemia.
Stevens MK; Yaksh TL
J Cereb Blood Flow Metab; 1990 Jan; 10(1):77-88. PubMed ID: 2153692
[TBL] [Abstract][Full Text] [Related]
5. Pre- and postischemic effects of the NMDA receptor antagonist dizocilpine maleate (MK-801) on collateral cerebral blood flow.
Robertson SC; Wetjen NM; Beer BJ; Loftus CM
J Neurosurg; 1997 Dec; 87(6):927-33. PubMed ID: 9384406
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the glutamate antagonist dizocilipine maleate (MK-801) on neurologic outcome in a canine model of complete cerebral ischemia: correlation with hippocampal histopathology.
Michenfelder JD; Lanier WL; Scheithauer BW; Perkins WJ; Shearman GT; Milde JH
Brain Res; 1989 Mar; 481(2):228-34. PubMed ID: 2655824
[TBL] [Abstract][Full Text] [Related]
7. The effects of nimodipine on cerebral blood flow and metabolism.
Forsman M; Fleischer JE; Milde JH; Steen PA; Michenfelder JD
J Cereb Blood Flow Metab; 1986 Dec; 6(6):763-7. PubMed ID: 3793808
[TBL] [Abstract][Full Text] [Related]
8. [Ketamine racemate and S-(+)-ketamine. Cerebrovascular effects and neuroprotection following focal ischemia].
Werner C; Reeker W; Engelhard K; Lu H; Kochs E
Anaesthesist; 1997 Mar; 46 Suppl 1():S55-60. PubMed ID: 9163280
[TBL] [Abstract][Full Text] [Related]
9. Parallel antioxidant and antiexcitotoxic therapy improves outcome after incomplete global cerebral ischemia in dogs.
Davis S; Helfaer MA; Traystman RJ; Hurn PD
Stroke; 1997 Jan; 28(1):198-204; discussion 204-5. PubMed ID: 8996512
[TBL] [Abstract][Full Text] [Related]
10. Degeneration of hippocampal CA1 neurons following transient ischemia due to raised intracranial pressure: evidence for a temperature-dependent excitotoxic process.
Duhaime AC; Ross DT
Brain Res; 1990 Mar; 512(1):169-74. PubMed ID: 1970944
[TBL] [Abstract][Full Text] [Related]
11. Alkalemia reduces recovery from global cerebral ischemia by NMDA receptor-mediated mechanism.
Hurn PD; Koehler RC; Traystman RJ
Am J Physiol; 1997 Jun; 272(6 Pt 2):H2557-62. PubMed ID: 9227531
[TBL] [Abstract][Full Text] [Related]
12. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
Nellgård B; Wieloch T
J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
[TBL] [Abstract][Full Text] [Related]
13. [The effect of sufentanil on cerebral blood flow, cerebral metabolism and the CO2 reactivity of the cerebral vessels in man].
Stephan H; Gröger P; Weyland A; Hoeft A; Sonntag H
Anaesthesist; 1991 Mar; 40(3):153-60. PubMed ID: 1827962
[TBL] [Abstract][Full Text] [Related]
14. Intraventricular dexmedetomidine decreases cerebral blood flow during normoxia and hypoxia in dogs.
McPherson RW; Koehler RC; Kirsch JR; Traystman RJ
Anesth Analg; 1997 Jan; 84(1):139-47. PubMed ID: 8989015
[TBL] [Abstract][Full Text] [Related]
15. Degeneration of neurons in the thalamic reticular nucleus following transient ischemia due to raised intracranial pressure: excitotoxic degeneration mediated via non-NMDA receptors?
Ross DT; Duhaime AC
Brain Res; 1989 Oct; 501(1):129-43. PubMed ID: 2553211
[TBL] [Abstract][Full Text] [Related]
16. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
Buchan AM; Slivka A; Xue D
Brain Res; 1992 Mar; 574(1-2):171-7. PubMed ID: 1386274
[TBL] [Abstract][Full Text] [Related]
17. Nicardipine increases cerebral blood flow but does not improve neurologic recovery in a canine model of complete cerebral ischemia.
Sakabe T; Nagai I; Ishikawa T; Takeshita H; Masuda T; Matsumoto M; Tateishi A
J Cereb Blood Flow Metab; 1986 Dec; 6(6):684-90. PubMed ID: 3793804
[TBL] [Abstract][Full Text] [Related]
18. MK-801 reduced cerebral ischemic injury by inducing hypothermia.
Corbett D; Evans S; Thomas C; Wang D; Jonas RA
Brain Res; 1990 Apr; 514(2):300-4. PubMed ID: 2162711
[TBL] [Abstract][Full Text] [Related]
19. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.
Park CK; Nehls DG; Graham DI; Teasdale GM; McCulloch J
Ann Neurol; 1988 Oct; 24(4):543-51. PubMed ID: 2853604
[TBL] [Abstract][Full Text] [Related]
20. Postischemic canine cerebral blood flow is coupled to cerebral metabolic rate.
Michenfelder JD; Milde JH; Katusić ZS
J Cereb Blood Flow Metab; 1991 Jul; 11(4):611-6. PubMed ID: 2050748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
